Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in AMRX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 26.6M | $459.8M | +8.3% | 8.318% | 0.01% |
| 2 | TPG GP A, LLC | 12.3M | $213.4M | 0.0% | 3.861% | 4.27% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 12.1M | $210.1M | +7.2% | 3.801% | 0.01% |
| 4 | Rubric Capital Management LP | 10.2M | $176.0M | -7.9% | 3.184% | 1.61% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 7.7M | $133.5M | +1.7% | 2.414% | 0.00% |
| 6 | STATE STREET CORP | 7.4M | $127.3M | +8.3% | 2.304% | 0.00% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 5.8M | $100.3M | +1.8% | 1.815% | 0.02% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 5.1M | $89.0M | +13.1% | 1.609% | 0.00% |
| 9 | MORGAN STANLEY | 4.1M | $71.1M | -11.4% | 1.287% | 0.00% |
| 10 | Neuberger Berman Group LLC | 3.9M | $67.3M | +5.6% | 1.217% | 0.02% |
| 11 | Invesco Ltd. | 3.5M | $60.6M | +9.8% | 1.097% | 0.00% |
| 12 | Nuveen, LLC | 3.3M | $57.6M | +2.5% | 1.041% | 0.01% |
| 13 | Allspring Global Investments Holdings, LLC | 3.3M | $55.9M | +29.3% | 1.032% | 0.09% |
| 14 | GOLDMAN SACHS GROUP INC | 3.0M | $52.2M | +5.2% | 0.944% | 0.00% |
| 15 | Assenagon Asset Management S.A. | 2.4M | $42.3M | -20.3% | 0.766% | 0.03% |
| 16 | Nantahala Capital Management, LLC | 2.3M | $39.3M | -20.2% | 0.711% | 0.65% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1M | $37.2M | -1.7% | 0.672% | 0.00% |
| 18 | NORTHERN TRUST CORP | 1.9M | $33.1M | +12.2% | 0.600% | 0.00% |
| 19 | AMERIPRISE FINANCIAL INC | 1.6M | $27.4M | -15.2% | 0.495% | 0.01% |
| 20 | Westshore Wealth, LLC | 1.4M | $23.7M | -0.6% | 0.428% | 7.34% |
| 21 | BlackBarn Capital Partners LP | 1.3M | $22.5M | -21.2% | 0.407% | 1.90% |
| 22 | Penn Capital Management Company, LLC | 1.2M | $20.5M | -1.3% | 0.370% | 1.30% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 1.2M | $20.2M | +1.3% | 0.366% | 0.00% |
| 24 | CITADEL ADVISORS LLC | 1.1M | $19.9M | +85.3% | 0.359% | 0.00% |
| 25 | Bank of New York Mellon Corp | 1.0M | $17.6M | +11.1% | 0.318% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in AMRX — a direct measure of their conviction.
Filings activity in AMRX during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new AMRX position in Q2 2026
Institutions that fully closed their AMRX position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 310 | 1.6% | 51.19% | +1.09 pp | $2.76B | +42% |
| Q1 2026 | 315 | +15% | 50.10% | +1.67 pp | $1.94B | +2.2% |
| Q4 2025 | 274 | +11% | 48.43% | +1.37 pp | $1.90B | +30% |
| Q3 2025 | 246 | +5.1% | 47.06% | +2.71 pp | $1.46B | +33% |
| Q2 2025 | 234 | +0.0% | 44.35% | +4.55 pp | $1.10B | +5.6% |
| Q1 2025 | 234 | +19% | 39.80% | +3.89 pp | $1.04B | +18% |
| Q4 2024 | 197 | +8.8% | 35.91% | 5.65 pp | $880M | 18% |
| Q3 2024 | 181 | — | 41.56% | — | $1.07B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying AMRX stock.
Based on Q2 2026 13F filings, institutional ownership of Amneal Pharmaceuticals, Inc. stands at 51.2%, held across 310 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of AMRX, with approximately 26,562,093 shares worth $0.46B as of Q2 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of AMRX, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for AMRX is 54 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
41 institutions opened new positions in AMRX during Q2 2026, while 50 fully exited. 238 added to existing positions and 21 trimmed.
AMRX institutional ownership rose by 1.09 percentage points quarter-over-quarter, with a net change of -5 holders.
The top 10 institutions account for 59.7% of all reported 13F value in AMRX, and the top 25 account for 78.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Amneal Pharmaceuticals, Inc. (AMRX) Institutional Ownership